share_log

iBio Inc | 8-K: Current report

iBio Inc | 8-K: Current report

iBio Inc | 8-K：重大事件
美股SEC公告 ·  05/20 07:00

Moomoo AI 已提取核心信息

On May 17, 2024, iBio Inc, through its subsidiary iBio CDMO LLC, entered into a definitive agreement with The Board of Regents of the Texas A&M University System to sell a property comprising land, improvements, and personal property for $8.5 million. The property sale is expected to close by May 31, 2024, subject to certain conditions. Concurrently, iBio CDMO amended its credit agreement with Woodforest National Bank, setting the term loan maturity to May 31, 2024, or earlier upon certain conditions. The outstanding balance of the term loan is approximately $13.1 million as of May 14, 2024. Additionally, iBio CDMO and iBio Inc have entered into a settlement agreement with the bank, agreeing to pay the sale proceeds from the property and issue a pre-funded warrant to the lender to cover the remaining balance. The warrant is exercisable for 1,560,570 shares of iBio Inc's common stock at a nominal price, equating to an indebtedness deficiency amount of approximately $4.5 million. The settlement will release both parties from any claims up to the closing date of the property sale.
On May 17, 2024, iBio Inc, through its subsidiary iBio CDMO LLC, entered into a definitive agreement with The Board of Regents of the Texas A&M University System to sell a property comprising land, improvements, and personal property for $8.5 million. The property sale is expected to close by May 31, 2024, subject to certain conditions. Concurrently, iBio CDMO amended its credit agreement with Woodforest National Bank, setting the term loan maturity to May 31, 2024, or earlier upon certain conditions. The outstanding balance of the term loan is approximately $13.1 million as of May 14, 2024. Additionally, iBio CDMO and iBio Inc have entered into a settlement agreement with the bank, agreeing to pay the sale proceeds from the property and issue a pre-funded warrant to the lender to cover the remaining balance. The warrant is exercisable for 1,560,570 shares of iBio Inc's common stock at a nominal price, equating to an indebtedness deficiency amount of approximately $4.5 million. The settlement will release both parties from any claims up to the closing date of the property sale.
2024年5月17日，iBio Inc通过其子公司iBio CDMO LLC与德克萨斯农工大学系统董事会达成最终协议，以850万美元的价格出售包括土地、改善和个人财产在内的财产。此次房地产销售预计将于2024年5月31日结束，但须遵守某些条件。同时，iBio CDMO修改了与伍德福里斯特国家银行的信贷协议，将定期贷款的到期日定为2024年5月31日，或在某些条件下更早。截至2024年5月14日，定期贷款的未偿余额约为1,310万美元。此外，iBio CDMO和iBio Inc已与该银行签订了和解协议，同意支付该物业的出售收益，并向贷款人签发预先注资的认股权证以弥补剩余余额。认股权证可按名义价格行使iBio Inc的1,560,570股普通股，相当于约450万美元的负债赤字。该和解协议将解除双方在房地产销售截止日期之前的任何索赔。
2024年5月17日，iBio Inc通过其子公司iBio CDMO LLC与德克萨斯农工大学系统董事会达成最终协议，以850万美元的价格出售包括土地、改善和个人财产在内的财产。此次房地产销售预计将于2024年5月31日结束，但须遵守某些条件。同时，iBio CDMO修改了与伍德福里斯特国家银行的信贷协议，将定期贷款的到期日定为2024年5月31日，或在某些条件下更早。截至2024年5月14日，定期贷款的未偿余额约为1,310万美元。此外，iBio CDMO和iBio Inc已与该银行签订了和解协议，同意支付该物业的出售收益，并向贷款人签发预先注资的认股权证以弥补剩余余额。认股权证可按名义价格行使iBio Inc的1,560,570股普通股，相当于约450万美元的负债赤字。该和解协议将解除双方在房地产销售截止日期之前的任何索赔。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间